Radiopharmacy, radionanopharmacology and translational molecular imaging
RADIOMIN
VU University Medical Center
Ámsterdam, HolandaPublicaciones en colaboración con investigadores/as de VU University Medical Center (5)
2020
-
COVID-19 and the brain: impact on nuclear medicine in neurology
European Journal of Nuclear Medicine and Molecular Imaging
-
Proven validity and management impact of amyloid imaging in Alzheimer’s disease—repetita juvant
European Journal of Nuclear Medicine and Molecular Imaging
2017
-
Position statement on radiopharmaceutical production for clinical trials
EJNMMI Radiopharmacy and Chemistry, Vol. 2, Núm. 1
2015
-
Untangling the web of European regulations for the preparation of unlicensed radiopharmaceuticals: A concise overview and practical guidance for a risk-based approach
Nuclear Medicine Communications, Vol. 36, Núm. 5, pp. 414-422
2014
-
Radiopharmaceuticals are special, but is this recognized? The possible impact of the new Clinical Trials Regulation on the preparation of radiopharmaceuticals
European Journal of Nuclear Medicine and Molecular Imaging